Welcome to RPPEO's Drug Availability Database, a one stop site for information on drug availability for Ontario Paramedicine.
This database covers drugs that are used under the Advance Life Support Patient Care Standards (v5.2 10Jul2023), including those drugs under research protocols or expected in the near future. The purpose of this database is to provide information on drug availability so that Paramedic Services, Base Hospitals, and the Ministry of Health can proactively manage drug shortages, thus ensuring the residents of Ontario have access to appropriate and equitable healthcare.
The Drug Availability Database is maintained by the Regional Paramedic Program for Eastern Ontario (RPPEO) on a publicly accessible site, with data manually entered, primarily from Health Canada's Drug Product Database, Drug Shortages Canada, and the Government of Canada's Recalls and Safety Alerts. Secondary sources include ad hoc updates on drug availability, expiry date extensions, recall notices, etc. from paramedic services, pharmaceutical suppliers, and manufacturers. We welcome drug availability information from users of the Drug Availability Database; please email information to RPPEO-Quality@toh.ca
Using the Drug Availability Database
Drugs are listed in alphabetical order of active ingredient, then manufacturer and trade name. Included in the Drug (Active Ingredient) column is the ATC code, and the Equipment Standards (v3.7 01Feb2023) requirements.
The drug Status is current to the last modified date/time shown directly under the title of this page, according to the legend below. The last two columns, Notes and JIRA, are only completed if applicable; the former containing relevant information, while the later contains restricted-access organisation-specific case management links.
If the drug preparation used within your Paramedic Service is not included in the Drug Availability Database, please email the particulars to RPPEO-Quality@toh.ca and we will add these.
For technical issues please email RPPEOBHITS@rppeo.ca
Drug Status Legend
Status | Meaning |
---|---|
Available | No Drug Shortage report and no Paramedic Services reporting supply issues |
Available | No Drug Shortage reported and no Paramedic Services reporting supply issues, but there is information to consider |
Supplier Issue | No Drug Shortage report, but Paramedic Services reporting supply issues |
Anticipated Shortage | Anticipated Drug Shortage reported |
Shortage | Drug Shortage reported |
Discontinued | Drug has been discontinued but supply is potentially still in use until date indicated. Will be removed from list after stated date. |
(T3) | May be combined with Anticipated Shortage, Shortage, or Discontinuation. Represents the potential for highest impact on Canada's healthcare |
Drug Availability Database
Drug (Active Ingredient) | Manufacturer | Trade Name | DIN | Presentation | Status | Notes | JIRA |
---|---|---|---|---|---|---|---|
AcetaminophenN02BE01 All units | Apotex | Acetaminophen Tablets USP | 02362244 | 500 mg tablet | Available | ||
Apotex | Acetaminophen Tablets USP | 02362422 | 325 mg tablet | Available | |||
Apotex | APO-Acetaminophen | 00544981 | 325 mg tablet | Available | |||
Cellchem Pharmaceuticals | Acetaminophen Tablets Extra Strength | 02252813 | 500 mg tablet | Available | |||
Cellchem Pharmaceuticals | Acetaminophen Tablets Regular Strength | 02252805 | 325 mg tablet | Available | |||
JAMP Pharma | JAMP Acetaminophen 325 | 01938088 | 325 mg tablet | Available | |||
JAMP Pharma | JAMP Acetaminophen 500 | 01939122 | 500 mg tablet | Available | |||
JAMP Pharma | JAMP Acetaminophen Blazon 500 | 02355299 | 500 mg tablet | Shortage | |||
Laboratoire Riva | Acetaminophene Blason Shield | 02362201 | 500 mg tablet | Shortage | |||
Laboratoire Riva | Acetaminophene comprime tablet | 02022222 | 500 mg tablet | Shortage | |||
Laboratoire Riva | Acetaminophene comprime tablet | 02022214 | 325 mg tablet | Available | |||
Laboratories Trianon | Acetaminophen Tab USP | 00789798 | 500 mg tablet | Available | |||
Laboratories Trianon | Acetaminophen Tab USP | 00789801 | 325 mg tablet | Available | |||
McNeil Consumer Healthcare | Tylenol extra strength | 00559407 | 500 mg tablet | Available | |||
McNeil Consumer Healthcare | Tylenol rapid release | 00863270 | 500 mg tablet | Available | |||
McNeil Consumer Healthcare | Tylenol regular strength | 00559393 | 325 mg tablet | Available | |||
Teva | Novo-Gesic | 00389218 | 325 mg tablet | Available | |||
Teva | Novo-Gesic Forte | 00482323 | 500 mg tablet | Available | |||
Vita Health Products | Acetaminophen Tablets | 00605751 | 325 mg tablet | Available | |||
Vita Health Products | Extra strength acetaminophen | 02285797 | 500 mg tablet | Available | |||
Vita Health Products | Extra strength acetaminophen tablets | 00605778 | 500 mg tablet | Available | |||
Zee Medical | Painaid Free Acetaminophen Tablets | 02144514 | 500 mg tablet | Available | |||
AdenosineC01EB10 ACP units | Fresenius Kabi | Adenosine Injection | 02267659 | 3 mg/ml in 2 ml vial | Available | ||
Fresenius Kabi | Adenosine Injection | 02457474 | 6 mg in 2 ml prefilled syringe | Available | |||
Fresenius Kabi | Adenosine Injection | 02457482 | 12 mg in 4 ml prefilled syringe | Available | |||
AmiodaroneC01BD01 ACP units if not carrying lidocaine injection | Fresenius Kabi | Amiodarone hydrochloride injection | 02245248 | 50 mg/ml in 3 ml vial | Shortage | ||
JAMP Pharma | Amiodarone hydrochloride injection | 02423227 | 50 mg/ml in 3 ml vial | Shortage | |||
Sandoz | Amiodarone hydrochloride injection | 02242325 | 50 mg/ml in 3 ml vial | Available | |||
50 mg/ml x 9 ml vial | Available | ||||||
Antibiotic eye dropsChem-Ex Auxiliary | |||||||
Antibiotic ointmentSpecial Event Auxiliary | |||||||
ASA (Acetylsalicylic acid)B01AC06 All units | Altamed Pharma | ASA | 02497115 | 80 mg chewable tablet | Available | ||
Bayer | Aspirin 81 mg quick chews | 02289970 | 81 mg chewable tablet | Available | |||
Biomed Pharma | BIO-ASA | 02515687 | 80 mg chewable tablet | Available | |||
JAMP Pharma | JAMP-ASA Chew | 02269139 | 80 mg chewable tablet | Available | |||
Laboratoire Riva | RIVASA Croquable - Tab | 02202352 | 80 mg chewable tablet | Available | |||
Mantra Pharma | M-ASA Croquable | 02429950 | 80 mg chewable tablet | Available | |||
Odan Laboratories | ASATAB Chewable Tablets | 02280167 | 80 mg chewable tablet | Available | |||
Pendopharm | Entrophen Chewable | 02243974 | 81 mg chewable tablet | Available | |||
Pharmascience | ASA daily low dose | 02394790 | 81 mg chewable tablet | Available | |||
Pharmascience | ASAPHEN | 02009013 | 80 mg chewable tablet | Available | |||
Pro Doc | PRO-AAS (Croquable) | 02311518 | 80 mg chewable tablet | Available | |||
AtropineA03BA01 ACP units | Labortoire Aguettant | Atropine Sulfate Injection | 02426277 | 1 mg in 5 ml prefilled syringe | Available | ||
Pfizer | Atropine Sulfate Injection USP Abboject | 00328154 | 1 mg in 10 ml prefilled syringe | Available | |||
Atropine Sulfate Injection USP LifeShield | 1 mg in 10 ml prefilled syringe | Available | |||||
Buprenorphine/NaloxoneN07BC51 Not yet implemented | Indivior | Suboxone | 02295709 | 8 mg/2 mg SL tablet | Available | ||
Indivior | Suboxone | 02502348 | 8 mg/2 mg soluble film | Available | |||
Pharmascience | PMS-Buprenorphine-Naloxone | 02424878 | 8 mg/2 mg SL tablet | Available | |||
Teva | Teva-Buprenorphine/Naloxone | 02453916 | 8 mg/2 mg SL tablet | Available | |||
Calcium GluconateB05BB01 ACP units | Fresenius Kabi | Calcium Gluconate USP 10% | 02141019 | 100 mg/ml in 10 ml vial | Available | ||
DexamethasoneH02AB02 All units | Omega Laboratories | Dexamethasone Omega Unidose | 02387743 | 10 mg/ml x 1 ml vial | Available | ||
Omega Laboratories | Dexamethasone-Omega | 02204266 | 4 mg/ml x 5 ml vial | Available | |||
Omega Laboratories | Dexamethasone-Omega | 02204274 | 10 mg/ml x 1 ml vial | Shortage | |||
Sandoz | Dexamethasone Sodium Phosphate Inj USP | 00664227 | 4 mg/ml x 5 ml vial | Available | |||
Sandoz | Dexamethasone Sodium Phosphate Inj USP | 00874582 | 10 mg/ml x 1 ml | Available | |||
DextroseB05BA03 ACP/PCP (AIV) units Alternative names:
| B Braun | 10% Dextrose Injection USP | 01924427 | 10% in 500 ml IV bag | Available | ||
Baxter | 10% Dextrose Injection, USP | 00060364 | 10% in 500 ml IV bag | Available | |||
ICU Medical | Dextrose Injection USP | 00037974 | 50% in 50 ml | Available | |||
Omega Laboratories | Dextrose Injection | 02517132 | 50% in 50 ml vial | Shortage | Product is placed on allocation and is available to contract customers at 50% allocation rate. | ||
Pfizer | Dextrose Injection USP | 02468514 | 50% in 50 ml vial | Shortage | |||
ANSYR syringe | 50% in 50 ml prefilled syringe | Shortage | |||||
LifeShield syringe | 50% in 50 ml prefilled syringe | Shortage | |||||
DiazepamN05BA01 Chem-Ex Auxiliary | Sandoz | Diazepam injection USP | 00399728 | 5 mg/ml in 2 ml ampoules | Available | ||
DimenhyDRINATER06AA11 All units | Church & Dwight | Gravol IM | 00013579 | 50 mg/ml in ampoule | Available | ||
Hikma | DimenhyDRINATE Injection USP | 02428954 | 50 mg/ml x 1 ml ampoule | Available | |||
Sandoz | DimenhyDRINATE Injection USP | 00392537 | 50 mg/ml x 1 ml ampoule | Available | |||
DiphenhydrAMINE | Fresenius Kabi | DiphenhydrAMINE Hydrochloride Injection | 02369567 | 50 mg/ml in 1 ml vial | Available | ||
Omega Laboratories | Diphenist | 02219336 | 50 mg/ml in 1 ml vial | Shortage | |||
Sandoz | DiphenhydrAMINE Hydrochloride Injection USP | 00596612 | 50 mg/ml in 1 ml | Shortage | |||
DiphenhydrAMINE | JAMP Pharma | JAMP DiphenhydrAMINE | 02257548 | 25 mg tablet | Available | ||
JAMP Pharma | JAMP DiphenhydrAMINE | 02257556 | 50 mg tablet | Available | |||
Laboratoire Lalco | Dormiphen extra-forte comprime | 02237789 | 50 mg tablet | Available | |||
McNeil Consumer Healthcare | Benadryl allergy | 02017849 | 25 mg tablet | Available | |||
McNeil Consumer Healthcare | Extra strength Benadryl allergy | 02470144 | 50 mg tablet | Available | |||
Paladin Labs | Unisom | 01946986 | 50 mg tablet | Available | |||
Tanta Pharmaceuticals | Allergy formula extra strength | 02532484 | 50 mg tablet | Available | |||
Teva | Allernix | 02097583 | 25 mg tablet | Available | |||
Teva | Allernix extra strength | 02097575 | 50 mg tablet | Available | |||
Vita Health Products | Allergy formula | 02229492 | 25 mg tablet | Available | |||
Vita Health Products | Allergy formula extra strength | 02490943 | 50 mg tablet | Available | |||
DopamineC01CA04 ACP units | Baxter | Dopamine HCL 0.8mg/ml Dextrose 5% Inj USP | 00761850 | 0.8 mg/ml in 250 ml solution | Available | ||
EPINEPHrine 1:1,000 (1 mg/ml)C01CA24 All units | Hikma | EPINEPHrine Injection USP | 02435810 | 1 mg/ml in 1 ml ampoule | Anticipated Shortage | ||
Pfizer | EPINEPHrine Injection USP | 00721891 | 1 mg/ml in 1 ml ampoule | Available | |||
Searchlight Pharma | Adrenalin | 00155357 | 1 mg/ml in 1 ml ampoule | Available | |||
1 mg/ml in 30 ml vial | Available | ||||||
EPINEPHrine 1:10,000 (0.1 mg/ml)C01CA24 ACP units | Laboratoire Aguettant | EPINEPHrine Injection | 02521148 | 1 mg in 10 ml prefilled syringe | Available | ||
Pfizer | EPINEPHrine Injection USP, LifeShield | 00710814 | 1 mg in 10 ml prefilled syringe | Available | |||
FentanylN01AH01 Optional | Fresenius Kabi | Fentanyl Citrate Injection, USP | 02501554 | 50 mcg/ml in 2 ml vial | Available | ||
Hikma | Fentanyl Citrate Injection USP | 02385406 | 50 mcg/ml in 2 ml vial | Available | |||
JAMP Pharma | Fentanyl Citrate Injection | 02506963 | 50 mcg/ml in 2 ml vial | Available | |||
Sandoz | Fentanyl Citrate Injection USP | 02240434 | 50 mcg/ml in 2 ml vial | Available | |||
Sandoz | Fentanyl Citrate Injection USP | 02384124 | 50 mcg/ml in 2 ml vial | Available | |||
Sterimax | Fentanyl Injection BP | 02496143 | 50 mcg/ml in 2 ml ampoule | Available | |||
GlucagonH04AA01 All units | Eli Lilly Expected drug | BAQSIMI | 02492415 | 3 mg powder in nasal dosing device | Available | ||
Eli Lilly | Glucagon | 02243297 | 1 mg as powder for reconstitution | Discontinued (T3) | |||
Novo Nordisk | Glucagen | 02333619 | 1 mg as powder for reconstitution | Discontinued | |||
Novo Nordisk | Glucagen Hypokit | 02333627 | 1 mg as powder for reconstitution | Discontinued (T3) | |||
Glucose (oral)All units | Not considered a drug by Health Canada | ||||||
GlycopyrrolateA03AB02 Palliative | JAMP Pharma | Glycopyrrolate Injection USP | 02513749 | 0.2 mg/ml in 2 ml vial | Available | ||
Omega Laboratories | Glycopyrrolate injection | 02382857 | 0.2 mg/ml in 1 ml vial | Available | |||
0.2 mg/ml in 2 ml vial | Available | ||||||
Sandoz | Glycopyrrolate Injection USP | 02039508 | 0.2 mg/ml in 1 ml vial | Available | |||
0.2 mg/ml in 2 ml vial | Available | ||||||
Sterimax | Glycopyrrolate Injection USP | 02473879 | 0.2 mg/ml in 1 ml vial | Shortage | |||
Sterimax | Glycopyrrolate Injection USP | 02473895 | 0.2 mg/ml in 2 ml vial | Available | |||
HaloperidolN05AD01 Palliative | Fresenius Kabi | Haloperidol injection USP | 02406411 | 5 mg/ml in 1 ml vial | Available | ||
Omega Laboratories | Haloperidol injection | 02366010 | 5 mg/ml in 1 ml vial | Available | |||
Sandoz | Haloperidol injection USP | 00808652 | 5 mg/ml in 1 ml ampoule | Available | |||
HYDROmorphoneN02AA03 Palliative | Fresenius Kabi | HYDROmorphone Hydrochloride Injection, USP | 02491680 | 10 mg/ml in 1 ml vial | Available | ||
Fresenius Kabi | HYDROmorphone Hydrochloride Injection, USP | 02491699 | 2 mg/ml in 1 ml vial | Available | |||
JAMP Pharma | HYDROmorphone Hydrochloride Injection USP | 02529645 | 2 mg/ml in 1 ml vial | Available | |||
Sandoz | HYDROmorphone HP 10 | 02145928 | 10 mg/ml in 1 ml vial | Available | |||
Sandoz | HYDROmorphone Hydrochloride Injection USP | 02145901 | 2 mg/ml in 1 ml vial | Available | |||
Sterimax | HYDROmorphone Hydrochloride Injection HP 10 | 02460610 | 10 mg/ml in 1 ml vial | Available | |||
Sterimax | HYDROmorphone Hydrochloride Injection USP | 02460602 | 2 mg/ml in 1 ml vial | Available | |||
HydroxocobalaminV03AB33 Chem Ex | Serb SA | Cyanokit | 02375370 | 5 g powder for infusion in glass vial | Available | ||
IbuprofenM01AE01 All units | Apotex | Apo-Ibuprofen | 00441643 | 200 mg tablet | Available | ||
Apotex | Apo-Ibuprofen | 00506052 | 400 mg tablet | Available | |||
Apotex | Apo-Ibuprofen | 02439689 | 200 mg tablet | Available | |||
GlaxoSmithKline | Advil tablets | 01933558 | 200 mg tablet | Available | |||
JAMP Pharma | Ibuprofen | 02257912 | 200 mg tablet | Available | |||
JAMP Pharma | Ibuprofen | 02317338 | 400 mg tablet | Available | |||
McNeil Consumer Healthcare | Motrin | 02186934 | 200 mg tablet | Available | |||
McNeil Consumer Healthcare | Motrin | 02242658 | 400 mg tablet | Available | |||
Pharmascience | Extra Strength Ibuprofen | 02314770 | 400 mg tablet | Available | |||
Pharmascience | Ibuprofen Tablets | 02314754 | 200 mg tablet | Available | |||
Vita Health Products | Ibuprofen Tablets | 02272849 | 200 mg tablet | Available | |||
Vita Health Products | Ibuprofen Tablets | 02368072 | 200 mg tablet | Available | |||
KetamineN01AX03 ACP units | Sandoz | Ketamine Hydrochloride USP | 02246796 | 50 mg/ml in 10 ml vial | Available | ||
50 mg/ml in 2 ml vial | Available | ||||||
Searchlight Pharma | Ketalar | 00224405 | 50 mg/ml in 10 ml vial | Shortage | |||
KetorolacM01AB15 All units | Atnahs Pharma | TORADOL IM | 02162644 | 10 mg/ml in 1 ml ampoule | Available | ||
Fresenius Kabi | Ketorolac Tromethamine Injection, USP | 02244947 | 30 mg/ml in 1 ml vial | Available | |||
Juno Pharmaceuticals | Ketorolac Tromethamine Injection, USP | 02443376 | 30 mg/ml in 1 ml vial | Available | |||
Pfizer | Ketorolac Tromethamine Injection, USP | 02390582 | 30 mg/ml in 1 ml vial | Anticipated Shortage | |||
Sandoz | Ketorolac Tromethamine Injection, USP | 02239944 | 30 mg/ml in 1 ml vial | Available | |||
Lidocaine injectionC01BB01 ACP units if not carrying amiodarone | Aspen Pharmacare | Xylocard | 00001937 | 100 mg in 5 ml prefilled syringe | Available | ||
Laboratoire Aguettant | Lidocaine Hydrochloride injection | 02522268 | 100 mg in 5 ml prefilled syringe | Available | |||
Pfizer | Lidocaine Hydrochloride injection USP: Abboject | 00436208 | 100 mg in 5 ml prefilled syringe | Available | |||
Lidocaine Hydrochloride injection USP: Ansyr | 100 mg in 5 ml prefilled syringe | Shortage | |||||
Lidocaine Hydrochloride injection USP: LifeShield | 100 mg in 5 ml prefilled syringe | Shortage | |||||
Lidocaine sprayN01BB02 ACP units | Aspen Pharmacare | Xylocaine Spray | 02003767 | 10 mg/metered dose spray | Available | ||
Odan Laboratories | Lidoan endotracheal non-aerosol spray | 02231147 | 10 mg/metered dose spray | Available | |||
Methoxyflurane 99.9%Research Project | Endo Ventures | Penthrox | 2474727 | 3 ml bottle and inhaler | Available | ||
MidazolamN05CD08 ACP units | Fresenius Kabi | Midazolam injection | 02242905 | 5 mg/ml x 2 ml vial | Available | ||
Pfizer | Midazolam injection USP | 02382350 | 5 mg/ml x 2 ml vial | Available | |||
Pfizer | Midazolam injection USP | 02382385 | 5 mg/ml x 2 ml vial | Available | |||
Sandoz | Midazolam injection | 02240286 | 5 mg/ml x 2 ml vial | Available | |||
MorphineN02AA01 ACP units | Fresenius Kabi | Morphine Sulfate injection, USP | 02482746 | 10 mg/ml in 1 ml vial | Available | ||
JAMP Pharma | Morphine Sulfate injection | 02500728 | 10 mg/ml in 1 ml ampoule | Available | |||
JAMP Pharma | Morphine Sulfate injection | 02500736 | 15 mg/ml in 1 ml ampoule | Available | |||
Sandoz | Morphine Sulfate injection USP | 02382997 | 10 mg/ml in 1 ml ampoule | Available | |||
Sandoz | Morphine Sulfate injection USP | 00392561 | 15 mg/ml in 1 ml ampoule | Available | |||
Sandoz | Morphine Sulfate injection BP | 00392588 | 10 mg/ml in 1 ml ampoule | Available | |||
Sterimax | Morphine Sulfate injection BP | 02474980 | 15 mg/ml in 1 ml ampoule | Available | |||
NaloxoneV03AB15 All units | Hikma | Naloxone hydrochloride injection USP | 02382482 | 0.4 mg/ml in 1 ml ampoule | Available | ||
Hikma | Naloxone injectable | 02458578 | 0.4 mg/ml in 1 ml ampoule | Available | |||
Omega Laboratories | Injectable naloxone hydrochloride | 02455935 | 0.4 mg/ml in 1 ml vial | Available | |||
Sandoz | Naloxone HCL Injection | 02148706 | 0.4 mg/ml in 1 ml ampoule | Available | |||
Sandoz | Naloxone HCL Injection | 02148714 | 1 mg/ml in 2 ml vial | Available | |||
Sandoz | S.O.S. Naloxone hydrochloride injection | 02453258 | 0.4 mg/ml in 1 ml ampoule | Available | |||
NitroglycerinC01DA02 All units | BGP Pharma | Nitrostat | 00037613 | 0.3 mg SL tablet | Anticipated Shortage | ||
Mylan Pharmaceuticals | Mylan-Nitro Sublingual Spray | 02243588 | 0.4 mg/metered dose spray | Shortage (T3) | Expiry date extension | CMP-32011 | |
Sandoz | Rho-Nitro Pumpspray | 02238998 | 0.4 mg/metered dose spray | Available | CMP-32011 | ||
Sanofi-Aventis | Nitrolingual Pumpspray | 02231441 | 0.4 mg/metered dose spray | Shortage (T3) | CMP-32011 | ||
Ondansetron injectionA04AA01 Palliative | Auro Pharma | Auro-ondansetron injection | 02491524 | 2 mg/ml in 2 ml vial | Available | ||
Auro Pharma | Auro-ondansetron injection | 02491532 | 2 mg/ml in 2 ml vial | Available | |||
Auro Pharma | Ondansetron Injection BP | 02461420 | 2 mg/ml in 2 ml ampoule | Available | |||
Marcan Pharmaceuticals | Ondansetron Injection USP | 02503905 | 2 mg/ml in 2 ml vial | Available | |||
Sandoz | Ondansetron Hydrochloride Dihydrate Injection | 02274418 | 2 mg/ml in 2 ml ampoule | Available | |||
Sandoz | Ondansetron Injection USP | 02279428 | 2 mg/ml in 2 ml vial | Available | |||
Sterimax | Ondansetron Injection USP | 02464578 | 2 mg/ml in 2 ml vial | Available | |||
Ondansetron oralA04AA01 All units | Accel Pharma | Accel-Ondansetron | 02478927 | 4 mg tablet | Available | ||
Apotex | Apo-ondansetron | 02288184 | 4 mg tablet | Shortage | 10 BLS shortage, 30 Btl available | ||
Athena Pharamaceutiques | Athena-ondansetron ODT | 02444674 | 4 mg orally disintegrating tablet | Available | |||
Auro Pharma | Auro-ondansetron ODT | 02511282 | 4 mg orally disintegrating tablet | Shortage | |||
JAMP Pharma | JAMP-Ondansetron | 02313685 | 4 mg tablet | Available | |||
JAMP Pharma | Ondansetron ODT | 02519232 | 4 mg orally disintegrating tablet | Available | |||
Marcan Pharmaceuticals | Mar-Ondansetron | 02371731 | 4 mg tablet | Available | |||
Marcan Pharmaceuticals | Mar-Ondansetron ODT | 02514966 | 4 mg orally disintegrating tablet | Available | |||
Mint Pharmaceuticals | Mint-Ondansetron | 02305259 | 4 mg tablet | Available | |||
Mint Pharmaceuticals | Mint-Ondansetron ODT | 02487330 | 4 mg orally disintegrating tablet | Available | |||
Mylan Pharmaceuticals | Mylan-Ondansetron | 02297868 | 4 mg tablet | Available | |||
Natco Pharma | Nat-Ondansetron | 02417839 | 4 mg tablet | Available | |||
Pharmascience | PMS-Ondansetron | 02258188 | 4 mg tablet | Available | |||
Pharmascience | PMS-Ondansetron ODT | 02519445 | 4 mg orally disintegrating tablet | Available | |||
Sandoz | Ondansetron ODT | 02481723 | 4 mg orally disintegrating tablet | Available | |||
Sandoz | Sandoz-Ondansetron | 02274310 | 4 mg tablet | Available | |||
Sandoz | Zofran ODT | 02239372 | 4 mg orally disintegrating tablet | Discontinued 31 Jan 2025 | |||
Sanis Health | Ondansetron | 02421402 | 4 mg tablet | Available | |||
Takeda | Ondissolve | 02389983 | 4 mg oral soluble film | Available | |||
Teva | Teva-Ondansetron | 02296349 | 4 mg tablet | Available | |||
OxytocinH01BB02 All units | Fresenius Kabi | Oxytocin Injection USP | 02139561 | 10 units/ml in 1 ml vial | Available | ||
Pfizer | Oxytocin Injection USP | 00497398 | 10 units/ml in 1 ml ampoule | Shortage | |||
PralidoximeV03AB13 Chem Ex | Not marketed in Canada | ||||||
Salbutamol inhalation solutionR03AC02 All units | Pharmascience | PMS-Salbutamol | 02208229 | 2.5 mg in 2.5 ml nebule | Available | ||
Pharmascience | PMS-Salbutamol | 02208237 | 5 mg in 2.5 ml nebule | Available | |||
Teva | Teva-Salbutamol Sterinebs | 01926934 | 2.5 mg in 2.5 ml nebule | Available | |||
Teva | Teva-Salbutamol Sterinebs | 02173360 | 5 mg in 2.5 ml nebule | Available | |||
Salbutamol MDIR03AC02 All units | Apotex | Apo-Salbutamol HFA | 02245669 | 100 mcg/metered dose MDI | Anticipated Shortage | ||
Bausch Health | Airomir | 02232570 | 100 mcg/metered dose MDI | Available | |||
GlaxoSmithKline | Ventolin HFA | 02241497 | 100 mcg/metered dose MDI | Available | |||
Sanis Health | Salbutamol HFA | 02419858 | 100 mcg/metered dose MDI | Available | |||
Teva | Teva-Salbutamol HFA | 02326450 | 100 mcg/metered dose MDI | Available | |||
Sodium BicarbonateB05XA02 ACP units | Fresenius Kabi | Sodium Bicarbonate Injection, USP | 02486636 | 50 mEq in 50 ml vial | Available | ||
JAMP Pharma | Sodium Bicarbonate Injection USP | 02516225 | 50 mEq in 50 ml vial | Available | |||
Omega Laboratories | Sodium Bicarbonate Injection USP | 02467585 | 50 mEq in 50 ml vial | Available | |||
Pfizer | Sodium Bicarbonate Injection USP, ABBOJECT Syringe | 00261998 | 50 mEq in 50 ml prefilled syringe | Available | |||
Pfizer | Sodium Bicarbonate Injection USP, fliptop Vial | 50 mEq in 50 ml vial | Shortage | ||||
Pfizer | Sodium Bicarbonate Injection USP, LifeShield Syringe | 50 mEq in 50 ml prefilled syringe | Shortage | ||||
Sodium Chloride 0.9% (diluent)B05XA03 Not in equipment standards | Hikma | 0.9% Sodium Chloride Injection USP | 02304341 | 10 ml ampoule | Available | ||
Omega Laboratories | 0.9% Sodium Chloride Injection USP | 02150204 | 10 ml vial | Available | |||
Pfizer | Bacteriostatic Sodium Chloride Injection USP | 00037818 | 10 ml vial | Anticipated Shortage | |||
Pfizer | Sodium Chloride Injection USP | 00037796 | 10 ml vial | Available | |||
Sodium Chloride 0.9% (IV fluid)B05XA03 ACP/PCP (AIV) units | B. Braun Medical | 0.9% Sodium Chloride Injection USP | 01924303 | 100 ml IV bag | Available | ||
250 ml IV bag | Available | ||||||
500 ml IV bag | Available | ||||||
1000 ml IV bag | Available | ||||||
Baxter | 0.9% Sodium Chloride Injection, USP | 00060208 | 50 ml IV bag | Available | Recall notice | ||
100 ml IV bag | Available | ||||||
250 ml IV bag | Available | ||||||
500 ml IV bag | Available | ||||||
Fresenius Kabi | 0.9% Sodium Chloride Injection | 02395150 | 50 ml IV bag | Available | |||
100 ml IV bag | Available | ||||||
250 ml IV bag | Available | ||||||
500 ml IV bag | Available | ||||||
1000 ml IV bag | Available | ||||||
ICU Medical | Sodium Chloride Injection USP | 00037842 | 50 ml IV bag | Available | |||
100 ml IV bag | Available | ||||||
250 ml IV bag | Available | ||||||
500 ml IV bag | Available | ||||||
Sodium Thiosulfate 25%V03AB06 Chem Ex | Hope Pharmaceuticals | Sodium Thiosulfate injection USP | 02428393 | 250 mg/ml in 50 ml vial | Available | ||
Pfizer | Sodium Thiosulfate injection USP | 02137186 | 250 mg/ml in 10 ml vial | Available | |||
Seaford Pharmaceuticals | Seacalpyx | 02386666 | 250 mg/ml in 100 ml vial | Available | |||
Tranexamic AcidB02AA02 Expected drug | Auro Pharma | Tranexamic Acid injection | 02466015 | 100 mg/ml in 10 ml ampoule | Available | ||
JAMP Pharma | Tranexamic Acid injection | 02497328 | 100 mg/ml in 10 ml vial | Available | |||
Omega Laboratories | Tranexamic Acid injection | 02392763 | 100 mg/ml in 10 ml vial | Shortage | |||
Pfizer | Cyklokapron | 02064413 | 100 mg/ml in 10 ml ampoule | Available | |||
Sandoz | Tranexamic Acid injection BP | 02246365 | 100 mg/ml in 10 ml vial | Available | |||
Searchlight Pharma | ERFA-Tranexamic | 02457431 | 100 mg/ml in 10 ml vial | Available | |||
Water for Injection (flush/diluent)V07AB Not in equipment standards | Hikma | Sterile Water for Injection USP | 02299186 | 10 ml ampoule | Available | ||
10 ml vial | Available | ||||||
Omega Laboratories | Sterile Water for Injection USP | 00402257 | 10 ml vial | Available | |||
Pfizer | Sterile Water for Injection USP | 02142546 | 10 ml vial | Anticipated Shortage | |||
Xylometazoline 0.1%R01AA07 Optional | GlaxoSmithKline | Otrivin Medicated Cold & Allergy Relief | 00653330 | 0.1% spray, nasal spray | Available | ||
GlaxoSmithKline | Otrivin Medicated Cold & Allergy Relief with moisturizers | 02208903 | 0.1% spray, nasal spray | Available | |||
GlaxoSmithKline | Otrivin Medicated Complete Nasal Care | 02331403 | 0.1% spray, nasal spray | Available | |||
CRLS | Decongestant Nasal Spray | 02452812 | 0.1% spray, nasal spray | Available | |||
CRLS | Decongestant Nasal Spray with moisturizers | 02452863 | 0.1% spray, nasal spray | Available |